Healthcare / Gene Therapy
CMS Program Expands Access to Sickle Cell Gene Therapies
Thirty-three states, along with the District of Columbia and Puerto Rico, have signed on to the Centers for Medicare and Medicaid Services (CMS) “Cell and Gene Therapy Access Model.” This initiative aims to broaden access to gene therapies...